Clinical trial / 2015
In children aged 4–6 years, single doses of erythritol up to 15 g were well tolerated, with diarrhea or severe symptoms observed at 20 g and 25 g.
A multicenter trial examined the gastrointestinal tolerance of a single oral dose of erythritol (5, 15, 20, or 25 g) versus an isosweet sucrose placebo in a 250-ml beverage consumed between meals by children aged 4-6 years. Statistically significantly more episodes of diarrhea and/or severe GI symptoms occurred in the 20 and 25 g groups compared with placebo, but not in the 5 and 15 g groups. Stool consistency on the Bristol stool scale was lower in the 15, 20, and 25 g groups during the first 24 hours, while nausea, vomiting, borborygmi, excess flatus, and abdominal pain did not differ significantly from placebo at any dose. The researchers concluded that up to 15 g (0.73 g/kg body weight) was well tolerated, serving as the no observed effect level for diarrhea or severe GI symptoms.
- Study type
- Multicenter, double-blind, randomized crossover trial
- Who was studied
- 185 healthy young children aged 4-6 years (184 completed)
- What was measured
- Gastrointestinal responses, stooling patterns, and maximum tolerated dose over 48 hours
THE PAPER
Gastrointestinal tolerance of erythritol-containing beverage in young children: a double-blind, randomised controlled trial.
Jacqz-Aigrain E, Kassai B, Cornu C, Cazaubiel JM, Housez B, Cazaubiel M, Prével JM, Bell M, Boileau A, de Cock P. Eur J Clin Nutr, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.